A molecular explanation for the recessive nature of parkin-linked Parkinson’s disease
暂无分享,去创建一个
P. Mercier | H. Walden | L. Burchell | D. Spratt | G. Shaw | A. Purkiss | K. R. Barber | Helen Walden | Andrew Purkiss | Pascal Mercier | N. Manczyk | Gary S. Shaw | Donald E. Spratt | Lynn Burchell | R Julio Martinez-Torres | Yeong J. Noh | Noah Manczyk | Kathryn R. Barber | Jacob D. Aguirre | J. Aguirre | R. Julio Martinez-Torres | Y. J. Noh
[1] C. Duyckaerts,et al. Parkin Deficiency Delays Motor Decline and Disease Manifestation in a Mouse Model of Synucleinopathy , 2009, PloS one.
[2] S. Grzesiek,et al. NMRPipe: A multidimensional spectral processing system based on UNIX pipes , 1995, Journal of biomolecular NMR.
[3] David A. Snyder,et al. Identification of zinc-ligated cysteine residues based on 13Calpha and 13Cbeta chemical shift data. , 2006, Journal of biomolecular NMR.
[4] R. Deshaies,et al. RING domain E3 ubiquitin ligases. , 2009, Annual review of biochemistry.
[5] Z. Pan,et al. Selective Recruitment of an E2∼Ubiquitin Complex by an E3 Ubiquitin Ligase* , 2012, The Journal of Biological Chemistry.
[6] J. Huibregtse,et al. Regulation of catalytic activities of HECT ubiquitin ligases. , 2007, Biochemical and biophysical research communications.
[7] S. Minoshima,et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism , 1998, Nature.
[8] M. Ruberg,et al. The C289G and C418R missense mutations cause rapid sequestration of human Parkin into insoluble aggregates , 2003, Neurobiology of Disease.
[9] K. Lim,et al. Parkin Mediates Apparent E2-Independent Monoubiquitination In Vitro and Contains an Intrinsic Activity That Catalyzes Polyubiquitination , 2011, PloS one.
[10] J. C. Greene,et al. Immune responses , 2004 .
[11] Rachel E. Klevit,et al. UbcH7 reactivity profile reveals Parkin and HHARI to be RING/HECT hybrids , 2011, Nature.
[12] N. Hattori,et al. Diverse Effects of Pathogenic Mutations of Parkin That Catalyze Multiple Monoubiquitylation in Vitro* , 2006, Journal of Biological Chemistry.
[13] G. Marius Clore,et al. Using Xplor-NIH for NMR molecular structure determination , 2006 .
[14] Ignacio Marín,et al. Comparative genomics and protein domain graph analyses link ubiquitination and RNA metabolism. , 2006, Journal of molecular biology.
[15] K. Lim,et al. Jcb: Report , 2022 .
[16] E. Hirsch,et al. Parkin prevents mitochondrial swelling and cytochrome c release in mitochondria-dependent cell death. , 2003, Human molecular genetics.
[17] Dmitri I. Svergun,et al. Electronic Reprint Applied Crystallography Dammif, a Program for Rapid Ab-initio Shape Determination in Small-angle Scattering Applied Crystallography Dammif, a Program for Rapid Ab-initio Shape Determination in Small-angle Scattering , 2022 .
[18] Dmitri I. Svergun,et al. PRIMUS: a Windows PC-based system for small-angle scattering data analysis , 2003 .
[19] J. Wrana,et al. Autoinhibition of the HECT-Type Ubiquitin Ligase Smurf2 through Its C2 Domain , 2007, Cell.
[20] Conrad C. Huang,et al. UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..
[21] A. Brice,et al. Biochemical analysis of Parkinson's disease-causing variants of Parkin, an E3 ubiquitin-protein ligase with monoubiquitylation capacity. , 2006, Human molecular genetics.
[22] V. Hristova,et al. Identification of a Novel Zn2+-binding Domain in the Autosomal Recessive Juvenile Parkinson-related E3 Ligase Parkin* , 2009, Journal of Biological Chemistry.
[23] A. Brice,et al. A regulated interaction with the UIM protein Eps15 implicates parkin in EGF receptor trafficking and PI(3)K–Akt signalling , 2006, Nature Cell Biology.
[24] A. Whitworth,et al. Drosophila Parkin requires PINK1 for mitochondrial translocation and ubiquitinates Mitofusin , 2010, Proceedings of the National Academy of Sciences.
[25] K. Tomoo,et al. Crystal structure and molecular dynamics simulation of ubiquitin-like domain of murine parkin. , 2008, Biochimica et biophysica acta.
[26] A. Markham,et al. Features of the Parkin/Ariadne-like Ubiquitin Ligase, HHARI, That Regulate Its Interaction with the Ubiquitin-conjugating Enzyme, UbcH7* , 2001, The Journal of Biological Chemistry.
[27] R. Osman,et al. Autoinhibitory regulation of SCF-mediated ubiquitination by human cullin 1's C-terminal tail , 2008, Proceedings of the National Academy of Sciences.
[28] Ping Wang,et al. Structure of a c-Cbl–UbcH7 Complex RING Domain Function in Ubiquitin-Protein Ligases , 2000, Cell.
[29] Li Chen,et al. α-Synuclein and Parkin Contribute to the Assembly of Ubiquitin Lysine 63-linked Multiubiquitin Chains* , 2005, Journal of Biological Chemistry.
[30] T. Sixma,et al. The E3 ligase HOIP specifies linear ubiquitin chain assembly through its RING-IBR-RING domain and the unique LDD extension , 2012, The EMBO journal.
[31] N. Thakor,et al. Parkin Facilitates the Elimination of Expanded Polyglutamine Proteins and Leads to Preservation of Proteasome Function* , 2003, Journal of Biological Chemistry.
[32] R. Youle,et al. p62/SQSTM1 is required for Parkin-induced mitochondrial clustering but not mitophagy; VDAC1 is dispensable for both , 2010, Autophagy.
[33] Bruce A. Johnson,et al. NMR View: A computer program for the visualization and analysis of NMR data , 1994, Journal of biomolecular NMR.
[34] 北田 徹. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism , 1999 .
[35] T. Mizushima,et al. A non‐canonical UBA–UBL interaction forms the linear‐ubiquitin‐chain assembly complex , 2012, EMBO reports.
[36] A. Bax,et al. TALOS+: a hybrid method for predicting protein backbone torsion angles from NMR chemical shifts , 2009, Journal of biomolecular NMR.
[37] Dmitri I. Svergun,et al. Determination of the regularization parameter in indirect-transform methods using perceptual criteria , 1992 .
[38] H. Walden,et al. Regulation of Parkin E3 ubiquitin ligase activity , 2012, Cellular and Molecular Life Sciences.
[39] T. Dawson,et al. Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[40] M. Scheffner,et al. The Ubiquitin-conjugating Enzymes UbcH7 and UbcH8 Interact with RING Finger/IBR Motif-containing Domains of HHARI and H7-AP1* , 1999, The Journal of Biological Chemistry.
[41] See-Kiong Ng,et al. MDPD: an integrated genetic information resource for Parkinson's disease , 2009, Nucleic Acids Res..
[42] Kenneth Wu,et al. Structure of the C-terminal RING finger from a RING-IBR-RING/TRIAD motif reveals a novel zinc-binding domain distinct from a RING. , 2004, Journal of molecular biology.
[43] V. Hristova,et al. Structure of the Parkin in-between-ring domain provides insights for E3-ligase dysfunction in autosomal recessive Parkinson's disease , 2007, Proceedings of the National Academy of Sciences.
[44] Sunhong Kim,et al. Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin , 2006, Nature.
[45] A. Ferrús,et al. Parkin and relatives: the RBR family of ubiquitin ligases. , 2004, Physiological genomics.
[46] Marc Cruts,et al. Genetic Etiology of Parkinson Disease Associated with Mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 Genes: A Mutation Update , 2010, Human mutation.
[47] S. Yokoyama,et al. NMR structure of ubiquitin-like domain in PARKIN: gene product of familial Parkinson's disease. , 2003, Journal of biomolecular NMR.
[48] D. Vaux,et al. Structures of the cIAP2 RING Domain Reveal Conformational Changes Associated with Ubiquitin-conjugating Enzyme (E2) Recruitment* , 2008, Journal of Biological Chemistry.
[49] H. Walden,et al. Autoregulation of Parkin activity through its ubiquitin‐like domain , 2011, The EMBO journal.
[50] N. Hattori,et al. Parkin binds the Rpn10 subunit of 26S proteasomes through its ubiquitin‐like domain , 2003, EMBO reports.
[51] Greg L. Hura,et al. E2 interaction and dimerization in the crystal structure of TRAF6 , 2009, Nature Structural &Molecular Biology.
[52] P. Howley,et al. Structure of an E6AP-UbcH7 complex: insights into ubiquitination by the E2-E3 enzyme cascade. , 1999, Science.
[53] G. Shaw,et al. Solution structure of the E3 ligase HOIL‐1 Ubl domain , 2012, Protein science : a publication of the Protein Society.
[54] Shinsei Minoshima,et al. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase , 2000, Nature Genetics.
[55] K. Rittinger,et al. LUBAC synthesizes linear ubiquitin chains via a thioester intermediate , 2012, EMBO reports.
[56] I. Ial,et al. Nature Communications , 2010, Nature Cell Biology.
[57] C. Day,et al. RINGs hold the key to ubiquitin transfer. , 2012, Trends in biochemical sciences.
[58] K. Lim,et al. Familial-associated mutations differentially disrupt the solubility, localization, binding and ubiquitination properties of parkin. , 2005, Human molecular genetics.
[59] Craig J. Thalhauser,et al. Identification of histidine tautomers in proteins by 2D 1H/13C(delta2) one-bond correlated NMR. , 2003, Journal of the American Chemical Society.
[60] K. Borden. RING fingers and B-boxes: zinc-binding protein-protein interaction domains. , 1998, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[61] K. Wüthrich,et al. Torsion angle dynamics for NMR structure calculation with the new program DYANA. , 1997, Journal of molecular biology.
[62] Y. Imai,et al. Parkin Suppresses Unfolded Protein Stress-induced Cell Death through Its E3 Ubiquitin-protein Ligase Activity* , 2000, The Journal of Biological Chemistry.